Chemomab Therapeutics Ltd. — SC 13D/A Filings
17 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Chemomab Therapeutics Ltd. (CMMB), sorted by most recent first. Each row links to the full filing on EdgarLookup. Chemomab Therapeutics Ltd. has filed 17 SC 13D/A documents with the SEC since 2011. To view all SEC filings by Chemomab Therapeutics Ltd., see the full filings list.
All
10-K
10-Q
144
15-15D
20-F
20-F/A
3
4
424B3
424B4
424B5
425
6-K
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
F-3/A
F-4
F-4/A
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001178913-24-003877 | Nov 29, 2024 | — |
| SC 13D/A | AMENDMENT NO. 4 | 0000947871-24-000757 | Sep 16, 2024 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000947871-24-000279 | Mar 11, 2024 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-23-001083 | Nov 15, 2023 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-23-000013 | Jan 5, 2023 | — |
| SC 13D/A | SC 13D/A | 0001178913-22-004096 | Nov 17, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-21-117964 | Apr 15, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-323169 | Dec 21, 2020 | — |
| SC 13D/A | SC 13D/A | 0001104659-20-136945 | Dec 18, 2020 | — |
| SC 13D/A | SC 13D/A | 0001104659-20-065255 | May 22, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-091948 | Mar 31, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-006416 | Jan 13, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-19-326668 | Dec 31, 2019 | — |
| SC 13D/A | SC 13D/A | 0001144204-19-032515 | Jun 27, 2019 | — |
| SC 13D/A | PALISADE MEDICAL EQUITY I, LP | 0001085146-19-001003 | Feb 25, 2019 | — |
| SC 13D/A | SC 13D/A | 0001178913-13-000068 | Jan 8, 2013 | — |
| SC 13D/A | SC 13D/A | 0001178913-12-003451 | Dec 17, 2012 | — |